Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C
PLoS ONE, Volume 9, No. 11, Article e112592, Year 2014
Notification
URL copied to clipboard!
Background: IL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of IL28B expression. Individualization of interferon alfa-based therapies based on a combination of IL28B/IFN-L4 polymorphisms may help to optimize virologic outcome and economic resources. Copyright: